0001681087 2024-06-14 2024-06-14 true 0001681087 8-K/A 2024-06-14 AVROBIO, Inc. DE 001-38537 81-0710585 One Broadway 14th Floor Cambridge MA 02142 (617) 914-8420 false false false false Common Stock, $0.0001 par value per share AVRO NASDAQ false As previously disclosed, on January 30, 2024, AVROBIO, Inc., a Delaware corporation (“AVRO” or the “Company”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) by and among AVRO, Alpine Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of AVRO (“Merger Sub”), and Tectonic Therapeutic, Inc., a Delaware corporation (“Tectonic”), pursuant to which, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Tectonic (the “Merger”), with Tectonic continuing as a wholly owned subsidiary of AVRO and the surviving corporation of the Merger.